Title
DISPARITIES IN ACCESS TO CHEMOTHERAPY AMONG KENTUCKY STAGE IV NON-SMALL CELL LUNG CANCER PATIENTS
Year of Publication
2022
College
Public Health
Degree Name
Master of Public Health (M.P.H.)
Committee Chair
Thomas Tucker
Committee Member
Jaclyn McDowell
Committee Member
Jay Christian
Abstract
OBJECTIVE: This population-based retrospective cohort study examines the association of sociodemographic disparities with the receipt of chemotherapy among patients with metastatic non-small cell lung cancer in the Commonwealth of Kentucky in the precision oncology and immunotherapy era.
METHODS: Kentucky Cancer Registry data from 2010 through 2017 was analyzed using univariate, bivariate, unadjusted, and adjusted multivariate regressions to assess disparities in our population (N = 9490).
RESULTS:We found no significant difference in receipt of chemotherapy between sexes (OR 0.99, P=0.90) nor races (OR 1.12, P=0.22). Patients diagnosed in an Appalachia county were significantly less likely to receive chemotherapy (OR 0.71, P
Patients who were married or lived with a domestic partner were significantly more likely to receive chemotherapy (OR 1.71, P
CONCLUSIONS: Higher proportions of patients have received chemotherapy over time. Receipt of life-prolonging chemotherapy is associated with patients’ age, Appalachian status, marital/living status, insurance type, and tobacco use.
Recommended Citation
Brown, Joshua, "DISPARITIES IN ACCESS TO CHEMOTHERAPY AMONG KENTUCKY STAGE IV NON-SMALL CELL LUNG CANCER PATIENTS" (2022). Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.). 357.
https://uknowledge.uky.edu/cph_etds/357